July 14, 2026
Willkie represented Novacap and its portfolio company InVita Healthcare Technologies in InVita’s acquisition of MAK-SYSTEM from The Carlyle Group and other shareholders.
InVita, a provider of the world’s most comprehensive human biologics software solutions for blood, organ, and tissue workflows, recently announced the completion of its acquisition of MAK-SYSTEM, a global leader in blood management software solutions. The combination brings together two industry leaders with decades of experience supporting blood centers, transfusion services, hospitals, tissue banks, and healthcare providers worldwide.
Novacap is a leading investor and one of Canada’s most experienced private equity firms.
The Willkie team was led by partners Gavin Gordon, William Buchanan, Russell Leaf, Jared Fertman and Jason Pearl.
InVita, a provider of the world’s most comprehensive human biologics software solutions for blood, organ, and tissue workflows, recently announced the completion of its acquisition of MAK-SYSTEM, a global leader in blood management software solutions. The combination brings together two industry leaders with decades of experience supporting blood centers, transfusion services, hospitals, tissue banks, and healthcare providers worldwide.
Novacap is a leading investor and one of Canada’s most experienced private equity firms.
The Willkie team was led by partners Gavin Gordon, William Buchanan, Russell Leaf, Jared Fertman and Jason Pearl.
